Richard J. Benjamin - Aug 9, 2022 Form 4 Insider Report for CERUS CORP (CERS)

Role: Chief Medical Officer
Signature: Richard J. Benjamin, by Chrystal Menard, attorney-in-fact
Stock symbol: CERS
Transactions as of: Aug 9, 2022
Transactions value $: -$51,194
Form type: 4
Date filed: 8/11/2022, 07:05 PM
Previous filing: Mar 15, 2022
Next filing: Mar 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CERS	Common Stock	Sale	-$51.2K	-10K	-5.47%	$5.12	173K	Aug 9, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.

Content

This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.